A cell‐free testing platform to screen chemicals of potential neurotoxic concern across twenty vertebrate species by Arini, Adeline et al.
A CELL-FREE TESTING PLATFORM TO SCREEN CHEMICALS OF POTENTIAL NEUROTOXIC
CONCERN ACROSS TWENTY VERTEBRATE SPECIES
ADELINE ARINI,a,b KRITTIKA MITTAL,a,b PETER DORNBOS,a,c,d JESSICA HEAD,a JENNIFER RUTKIEWICZ,a,e
and NILADRI BASUa,b,*
aDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan, USA
bFaculty of Agricultural and Environmental Sciences, McGill University, Montreal, Quebec, Canada
cDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA
dInstitute for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA
eToxServices, Ann Arbor, Michigan, USA
(Submitted 8 February 2017; Returned for Revision 9 March 2017; Accepted 5 June 2017)
Abstract: There is global demand for new in vitro testing tools for ecological risk assessment. The objective of the present study was to
apply a set of cell-free neurochemical assays to screen many chemicals across many species in a relatively high-throughput manner. The
platformassessed7 receptors and enzymes thatmediate neurotransmissionofg-aminobutyric acid, dopamine, glutamate, and acetylcholine.
Each assay was optimized to work across 20 vertebrate species (5 fish, 5 birds, 7 mammalian wildlife, 3 biomedical species including
humans).We tested the screening assay platform against 80 chemicals (23 pharmaceuticals and personal care products, 20metal[loid]s, 22
polycyclic aromatic hydrocarbons and halogenated organic compounds, 15 pesticides). In total, 10 800 species–chemical–assay
combinations were tested, and significant differences were found in 4041 cases. All 7 assays were significantly affected by at least one
chemical in each species tested. Among the 80 chemicals tested, nearly all resulted in a significant impact on at least one species and one
assay. The 5 most active chemicals were prochloraz, HgCl2, Sn, benzo[a]pyrene, and vinclozolin. Clustering analyses revealed groupings
according to chemicals, species, and chemical–assay combinations. The results show that cell-free assays can screen a large number of
samples in a short period of time in a cost-effective manner in a range of animals not easily studied using traditional approaches. Strengths
and limitations of this approach are discussed, as well as next steps. Environ Toxicol Chem 2017;36:3081–3090.# 2017 SETAC
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INTRODUCTION
Thousands of chemicals and environmental samples need to
be evaluated for regulatory purposes. However, the current
testing paradigm is challenged as it mainly relies on animal
studies that are inefficient in the cost of time, money, and animal
lives [1–3]. These limitations were highlighted by the US
National Research Council in their report “Toxicity Testing in
the 21st Century: A Vision and a Strategy” [4]. A major
recommendation of the National Research Council report was to
develop and utilize in vitro tests to assist in assessing the
potential risk associated with exposures to chemicals and
complex environmental samples. In particular, the report
articulated the need to establish in vitro platforms that can
screen a large number of chemicals and samples (thousands) in a
relatively short period of time (days to weeks) and in a relatively
cost-effective manner.
To date, the development and application of in vitro tools
for testing chemicals and environmental samples have been
primarily focused on the human health community. Unfortu-
nately, such developed tools and the resulting information are
of limited use within the ecotoxicological sciences where
many more species and environmental contexts come under
scrutiny. Relatively few in vitro testing tools exist for
standard ecotoxicological test species, with even fewer
available for native species of ecological relevance. This is
problematic because the extrapolation of results across
species (i.e., from standard test species to native species of
ecological relevance) introduces tremendous uncertainty, as
does extrapolation from controlled laboratory tests to real-
world environments [5]. For example, native bird species [6]
and fish [7] can be more sensitive and/or respond differently
to chemicals than standard laboratory models. Such differ-
ences complicate decision-making and often necessitate
additional testing.
There is a great need to accelerate the development and
application of in vitro toxicity testing tools for the purposes of
ecological risk assessment [5]. Cell-free assays represent a
viable possibility (A. Arini, McGill University, Montreal,
Quebec, Canada, unpublished data). Cell-free assays are
simplified in vitro platforms that can help evaluate the potential
effects of a chemical or environmental sample on biochemical
processes, such as ligand-receptor binding or an enzymatic rate
of reaction. A great advantage of cell-free assays is that they are
amenable for use from any species from which tissue can be
obtained. This versatility is especially useful for ecological
species that are difficult to maintain under laboratory conditions
and which lack proven cell-based tools. Furthermore, cell-free
assays have formed an integral component of the US
Environmental Protection Agency’s (USEPA’s) ToxCast
program. ToxCast is an ambitious endeavor that is currently
comprised of nearly 1000 in vitro technologies/assays aimed at
providing cost-effective and rapid approaches to screen for
changes in biological activity in response to chemical exposure
mainly for the purposes of human health [8,9].
We have previously utilized cell-free neurochemical assays
to screen real-world effluent samples from pulp and paper
This article includes online-only Supplemental Data.
* Address correspondence to Niladri.basu@mcgill.ca
Published online 8 June 2017 in Wiley Online Library
(wileyonlinelibrary.com).
DOI: 10.1002/etc.3880
Environmental Toxicology and Chemistry, Vol. 36, No. 11, pp. 3081–3090, 2017
# 2017 SETAC
Printed in the USA
3081
mills [10] and wastewater-treatment plants [11], to compare
responses between mammalian wildlife (mink, river otters) and
biomedical models [12], and to study potential responses in an
Arctic marine mammal (ringed seals) that is difficult to study in
a controlled setting [13]. In the present study we scaled up our
activities and applied a set of cell-free neurochemical screening
assays to serve as a screening platform to evaluate many
chemicals across many species. Specifically, the platform
assessed 7 key receptors and enzymes that mediate neurotrans-
mission of g-aminobutyric acid (GABA), dopamine, glutamate,
and acetylcholine. Each assay was optimized to work across 20
diverse vertebrate species (5 fish, 5 birds, 7mammalian wildlife,
and 3 biomedical species including humans). We tested the
screening assay platform against 80 notable chemicals of
environmental concern to serve as a proof of concept that this
could be a new approach of particular interest to the community.
METHODS
General overview
The overall experimental design mirrors the approach taken
by the USEPA’s ToxCast program for the biochemical
screening of chemicals [8,9]. In short, a single concentration
(50mM) of each chemical (n¼ 80) was tested in each cell-free
in vitro assay (n¼ 7) for each species (n¼ 20). All assays were
performed in 96-well microplates. Each microplate consisted of
a single assay–species pair. All assay plates contained positive
(assay-specific) and negative (buffer-only) controls, as well as
pooled controls to address inter- and intraplate variability.
Brain tissues
Brain tissues were obtained from fish (n¼ 5 species), birds
(n¼ 5 species), mammalian wildlife (n¼ 7 species), and
biomedical organisms (n¼ 3 species including humans) from
a number of sources (Supplemental Data, Table S1). For each
species, brain tissue from a minimum of 6 individuals was
pooled, with efforts made to ensure that males and females were
equally represented. Pooling was used as a way to minimize
potential interindividual differences, which can be pursued in
future work. Whole brains were sampled for all species except
for the mammalian wildlife and humans in which the cerebral
cortex region was sampled. Cell membranes (for receptor
assays) and homogenates (for enzyme assays) of pooled brain
regions were prepared according to previous reports [14].
Aliquots were frozen on dry ice and stored at –80 8C until
required for assays.
Neurochemical receptor binding assays
Radioligand binding to the GABA receptor benzodiazepine
site (GABA-BZ), muscarinic acetylcholine receptor (mAChR),
N-methyl-d-aspartate receptor (NMDA), and dopamine-2 (D2)
receptors was performed using species-specific cellular mem-
branes plated in microplate wells containing a 1.0mM GF/B
glass filter (MultiScreenHTS) according to published meth-
ods [10,11]. Briefly, 30mg of cellular membrane preparations
were resuspended in 100mL of assay-specific buffer (see
Supplemental Data, Table S2 for specific methodological
details) and added to preconditioned microplate wells.
Membrane preparations were incubated under gentle agitation
with receptor-specific radioligands for 30 to 120min depending
on the receptor–ligand pair and subsequently terminated by
vacuum filtration. Filters were washed 6 times with buffer and
dried overnight before being soaked for 48 h in 30mL of
OptiPhase Supermix Cocktail (Perkin Elmer). Radioactivity
retained by the filter was quantified by liquid scintillation
counting in a microplate detector (Wallac 1450 Microbeta
Trilux; PerkinElmer).
The effect of test chemicals (see section Test chemicals) on
receptor binding was determined by adding the chemical to each
well just after adding the radioligand. All chemicals were
assayed in quadruplicate with slow shaking for different
incubation times and temperatures (Supplemental Data,
Table S2). The total binding was determined by incubating 6
wells/microplate with buffer instead of test chemical. Nonspe-
cific binding was determined by incubating 6 wells with
unlabeled assay-specific displacer. Intra- and interplate varia-
tions in receptor binding were determined by use of internal
controls.
Neurochemical enzyme activity assays
Enzymatic activity of glutamine synthetase (GS) was
measured in homogenates as described by Rutkiewicz
et al. [15]. Briefly, assay buffer (50mM imidazole, 12.5mM
sodium arsenate, 0.8mM ADP, 25mM l-glutamine, 25mM
hydroxylamine, 1mM manganese chloride) was added to each
well followed by the test chemicals in triplicate. In control wells,
chemicals were replaced by Tris buffer (negative control) or by
methionine sulfoximine (10mM) as a positive control. Next,
tissue homogenates were added rapidly to initiate the reaction.
Following incubation at 37 8C for 30min, a ferric chloride stop
solutionwas added to each well. Absorbance was read at 540 nm
in an HTS 7000 Plus Bioassay Reader (PerkinElmer). Enzyme
activity was determined by a colorimetric assay measuring the
production of g-glutamyl hydroxamate from glutamine.
The activity of monoamine oxidase (MAO) was measured in
homogenates according to published methods [10], with slight
modifications. Briefly, assay buffer (50mM tyramine, 50mM
10-acetyl-3, 7-dihydroxyphenoxazine, 100 mU horseradish
peroxidase) was added to each well, followed by the test
chemicals which were assayed in triplicate. As a negative
control, chemicals were replaced by Tris buffer, a mix of
100mM chlorgyline and/or 100mM deprenyl, and 5mM H2O2
was used as a positive control. Next, tissue homogenates and
Tris buffer were added to each well to initiate the reaction.
Plates were incubated at room temperature for 30min,
following which fluorescence (lex¼ 530 nm, lem¼ 590 nm)
of resorufin was measured every minute for 15min in an HTS
7000 Plus Bioassay Reader. Enzyme activity was calculated as
the production of resorufin per minute per milligram of protein.
The activity of the acetylcholine esterase (AChE) was
measured following the Ellman protocol. Briefly, Ellman
reagent and 5-50-dinitrobis-2-nitrobenzoate (DTNB,
1.125mM) were added to each well. For a negative control,
20mM galanthamine replaced the DTNB. Next, test chemicals
were added in triplicate. Reactions were initiated with the
addition of tissue homogenate and 1.875mM acetylthiocholine
iodide to each well. Absorbance was read in the HTS 7000 plate
reader every 30 s for 5min at 405 nm immediately after adding
acetylthiocholine iodide. Enzyme activity was determined by a
colorimetric assay measuring the production of 5-thio-2-nitro-
benzoic acid per minute and per milligram of protein.
Test chemicals
As a proof-of-concept activity we focused on 80 notable
environmental chemicals which were selected considering the
following: 1) chemical properties that make them persistent,
bioaccumulative, and toxic to fish, wildlife, and humans as
defined in the Great Lakes Water Quality Agreement Annex
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12 [16]; 2) identification by experts as an emerging chemical of
concern [17]; 3) listed as a priority substance by the
Comprehensive Environmental Response, Compensation, and
Liability Act of 1980 [18], also known as Superfund; 4)
commonly detected in waterways across the United States [19];
and/or 5) biomonitored in US residents as part of the Centers for
Disease Control’s National Health and Nutrition Examination
Survey [20]. The chemicals were grouped into 4 classes (number
of chemicals in parentheses) as follows: pharmaceuticals and
personal care products (n¼ 23),metal(loid)s (n¼ 20), polycyclic
aromatic hydrocarbons (PAHs) and halogenated organic com-
pounds (n¼ 22), and pesticides (n¼ 15). Specific details on each
of the chemicals, such as Chemical Abstracts Service number,
supplier, and solvent, are provided in Supplemental Data,
Table S3. All tested chemicals were>90% pure, and many were
predissolved in a range of solvents (i.e., DMSO, methanol,
hexane, acetone, nitric acid), all of which we have previously
tested for potential interferences at 5% v/v ratios with no
discernable effects. Chemicals were tested against the receptor
assays in quadruplicate (i.e., each chemical was tested in 4
different microplate wells for each species–assay pairing), and
for enzyme assays each chemical was tested in triplicate.
Data analyses
All assay results were inputted into an MS Excel document
that served as the main database for the present study.
Preliminary data analysis included tabulation of descriptive
statistics for all measurements to understand the basic
features of the data set. Because an edge effect was observed
in some of the microplates, we decided to use 3 of the 4
replicates for all chemical–assay–species data set (i.e.,
removed data from the outer edge wells). The observation
of an edge effect in particular assay plates (which we were
able to correct for) is not consistent with previous studies
performed in our or our colleagues’ laboratories; we discuss
the edge effect in the section Data quality. Following removal
of edge-based wells, all raw data points were normalized
to intraplate controls that were not exposed to any test
chemicals.
All data are represented as mean standard error unless
otherwise indicated. The critical level of significance for all
statistical analyses was set at a¼ 0.05. Because of the skewed
distribution of the data, nonparametric statistical tests were
performed. A Kruskal-Wallis analysis of variance was
performed to identify chemicals that elicited a response that
was significantly (p< 0.05) different from that of the negative
control in the same plate. Chemical–assay–species combina-
tions that caused either significant activation or inhibition of a
particular neurochemical receptor binding or enzyme activity
were flagged and are reported in the present study as
appropriate.
To explore for relationships and clustering among focal
variables (chemicals, species, assays), hierarchical analyses
were performed using Gene Cluster 3.0 and Java TreeView. The
findings were represented visually as heat maps with uncentered
Pearson correlations and reporting the maximum distance
between 2 items among all pairwise comparisons. The
correlation (r) measured at key cluster nodes is provided.
RESULTS AND DISCUSSION
Data quality
The present study was a relatively large screening study
aimed as a proof of concept to show that the underlying
approaches in past studies using a set of cell-free neurochemical
screening assays could be scaled up and serve as a screening
platform to evaluate many chemicals across many species.
While the main goal of the study was met and useful data were
obtained, there were 2 noteworthy aspects of data quality that
require discussion. First, variability in responses within and
across microplates occurs. In our past studies running these
same assays, the variation within and across plates was
generally <20%, as deemed by analyses of the internal pools.
Such was the case in the present study for many assays except
for receptor binding for D2 (32.4%), GABA-BZ (29.7%), and
mAChR (22%), and for enzyme activities for AChE (26.9%),
with the interplate variability indicated in parentheses. As
mentioned, an edge effect was observed in some assay
microplates. Although analytical precision upward of 30% is
acceptable in many cases using microplates (e.g., Organisation
for Economic Co-operation and Development H295R steroido-
genesis assay), such variability introduces “noise” into the
screening platform capabilities and needs to be carefully
reviewed and considered when trying to identify “hits.” Second,
a pattern emerged in some of the receptor binding assays in
which the top half of the microplate showed a higher signal than
the bottom half. Troubleshooting was performed for over 1 yr
with steps taken to carefully inspect the microplates (e.g., lot
numbers, discussions with the manufacturer), the equipment,
and assay processes (e.g., multichannel pipettes, liquid handling
and dispensing instruments, vacuuming plates) and to recali-
brate the scintillation counter. The pattern was observed in
19.4% of the receptor binding plates. Despite this challenge, the
data from the flagged plates were predictable (i.e., the increase
in binding was consistent), so we applied numerical corrections
to the resulting data. While these 2 issues do not diminish the
overall goal of the study, they need to be carefully considered
when interpreting the results from this particular study and
monitored in future efforts using these assays. However, we
note that in previous screening activities using similar assays by
our group [10,11] as well as in a subsequent study in preparation
for publication (larger in scope than the current; i.e., screening
USEPA ToxCast’s E1K library), the 2 challenges above were
not encountered.
Data overview
The general results of this chemical screening activity are
summarized in Figure 1, with key summaries provided in
Tables 1 and 2. In total, 10 800 species–chemical–assay
combinations were tested (20 species 80 chemicals 7
assays, though MAO and GS activities were only screened in
a subset of samples). Of these 10 800 species–chemical–assay
combinations, significant differences were found in 4041 cases
(37% of total). This frequency of hits is more than reported in
previous studies within the USEPA ToxCast program. For
example, a study of 976 chemicals screened across 331
enzymatic and receptor signaling assays yielded active assay–
chemical pairs in approximately 2% of all cases [21]. Another
ToxCast study on 309 chemicals evaluated across 292
biochemical targets reported that 10.3% of the assays were
susceptible to being affected by 7 or more chemicals [8]. The
relatively higher percentage of hits in the present study is not
surprising as we purposefully selected well-known environ-
mental chemicals, many of which are known neurotoxicants.
Also, each of the 80 chemicals was tested against 20 species
compared to the aforementioned platforms that are generally
focused on testing single chemicals against single species
through a range of assays.
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The number of active chemical–assay pairs is presented
Tables 1 and 2. All 7 assays were significantly affected by at
least one chemical in each species tested. Among the 80
chemicals tested, nearly all resulted in a significant impact on at
least one species and one assay (number active ranged from 71
to 80 chemicals depending on the species–assay pair).
Test chemicals
A total of 80 chemicals were tested, and each of them
affected at least one species and one assay. The chemicals were
categorized into 4 classes: pharmaceuticals and personal care
products (n¼ 23), metal(loid)s (n¼ 20), PAHs and halogenated
organic compounds (n¼ 22), and pesticides (n¼ 15); chemicals
within each of these categories were active on an average of
48.1/140, 36.1/140, 56.8/140, and 50.1/140 species–assay pairs,
respectively. In terms of number of species affected, the
chemicals within the pesticide group were the most active, with
8.3/20 species on average being impacted by each chemical,
followed by pharmaceuticals and personal care products (7.7/20
species), metal(loid)s (6.9/20 species), and PAHs and haloge-
nated organic compounds (6.2/20 species).
The 5 most active chemicals were prochloraz, HgCl2, Sn,
benzo[a]pyrene (BaP), and vinclozolin. Eachof these 5 chemicals
affected at least 60% of the species–assay pairs (Table 1). Other
chemicals that affected at least 50% of the species–assay pairs
studied included diethylstilboestrol, bisphenol A (BPA), mala-
thion, anthracene, indomethacin, 17a-ethinylestradiol (EE2),
ibuprofen, methylmercury, and methyl parathion. Chemicals that
affected <15% of the species–assay pairs studied included
triclosan, cholesterol, fluoride, and caffeine.
Clustering was used to identify which chemicals acted most
similarly in the cell-free neurochemical assays (Figure 2). The
clustering was ordered by response potency with cells in
Figure 2 ranging from red (negative values reflecting inhibition)
to blue (positive values reflecting activation) in comparison to
nonexposed samples. Four main clusters were identified and are
briefly described. The strongest grouping of chemicals was
found in cluster 1. Cluster 1 had 11 chemicals which were all
metal(loid)s (Cr, Cd, Mn, Co, Li, Ni, Al, Se, La, As, In;
r¼ 0.85). Interestingly, Hg and Pb were not present in cluster 1
even though they were among the most active chemicals.
Similarly, prochloraz (another highly active chemical) was not
found in any of the other clusters. Cluster 3 was another
grouping that contained chemicals from the same class and in
this case consisted of 11 pharmaceuticals and personal care
products (gemfibrozil, triclocarban, diethylstilboestrol, dexa-
methasone, ketoconazole, EE2, ibuprofen, indomethacin, 17b-
trenbolone, fadrazole, trilostane; r¼ 0.51). The other 2 clusters
contained chemicals from across categories, though some
similarities were noted within the clusters. Cluster 2 (r¼ 0.54)
included well-studied organic pesticides (parathion, malathion,
dieldrin, dichlorodiphenyldichloroethylene [DDE], glypho-
sate), PAHs (anthracene, fluoranthrene, phenanthrene, BaP),
and halogenated compounds (Aroclors 1254, 1232, 1260,
1016). Cluster 4 (r¼ 0.67) included chemicals that were
organophosphate flame retardants (tris[1-chloro-2-propyl]
phosphate [TCPP], tris[2-chloroethyl]phosphate [TCEP], tri-
cresyl phosphate [TCrP], tris[2-butoxyethyl]phosphate [TBEP],
tris[1,3-dichloro-2-propyl]phosphate [TDCPP]) and certain
personal care products (triclosan, cimetidine, cholesterol,
caffeine, acetaminophen).
Species comparisons
The 80 chemicals and 7 assays resulted in 540 chemical–
assay pairs tested for each animal species (Table 2). Across the
20 species studied, 166 to 237 (of 540) chemical–assay pairs
showed significant results. Among the species, yellow perch
(237), pilot whale (236), and humans (233) exhibited the highest
numbers of chemical–assays pairs affected (number of
chemical–assay pairs affected indicated in parentheses). There
was no clear distinction in species differences (in terms of
numbers of chemical–assay pairs affected) with respect to their
taxonomic grouping, thoughwe note that the 2marinemammals
(narwhals, 182/540; ringed seal, 166/540) had the fewest
affected chemical–assay pairs. While these types of results do
not permit valid or robust estimates of differences in species
sensitivity to be calculated, there are few approaches that permit
such a wide range of animals to be studied together; and the
current work lays the foundation for future efforts that may help
improve this aspect of testing across species.
The species–species clustering analyses showed high
correlations among all species assayed, with only positive
correlations measured as the r value ranged from 0.25 to 0.94
(Figure 3). Some fishes and birds were highly correlated (king
mackerel, chicken, zebra finch, goldfish, yellow perch;
r¼ 0.83), though in general there were no obvious groupings
according to the different vertebrate groups (mammals, birds,
fish, biomedical species) or other types of pairings (e.g., aquatic
and terrestrial species). Rainbow trout exhibited the most
differences with the others (34% similarity averaged with other
species), with the least similarity in responses found between
rainbow trout and humans (10.4%) and between rainbow trout
and ringed seal (25.2%). In contrast, the highest similarity was
measured between mink and pilot whale (82.5%) and between
mink and bald eagle (79.9%).
Neurochemical assays
The 80 chemicals were tested across 20 test species, thus
resulting in 1600 chemical–species pairs per assay. The 2 assays
that were most affected were GS and MAO with 730/1200 and
614/1200 active chemical–assay pairs and an average of 12.2/20
and 10.2/20 species impacted per chemical, respectively. The 2
assays the least affected were D2 and GABA-BZ with 386/1600
and 369/1600 active chemical–assay pairs and an average of 4.8/
20 species impacted per chemical for both assays, respectively.
Figure 1. Venn diagram of the active “hits” among the 10 800 chemical–
species–assay triads studied.
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Table 1. A summary of the significantly active chemical–assay pairs across the 20 species noted for each of the 80 test chemicals and 7 assaysa
% Species with significant hits for each chemical–assay pairing
Chemicals D2
GABA
BZ NMDA mAChR AChE GS MAO
Species–assay pairs affected by the
chemical listed
Metal(loid)s
HgCl 70 55 25 80 90 60 95 95/140
Sn 20 75 45 95 65 65 85 90/140
MeHg 45 45 35 50 25 75 80 71/140
Ce 5 15 15 90 20 50 95 58/140
Pb 35 15 15 90 30 45 65 59/140
Ta 15 10 5 65 15 20 90 44/140
Y 55 30 10 15 20 90 35 51/140
Cu 10 10 20 45 40 50 65 48/140
Se 10 15 25 25 10 70 30 37/140
Cd 25 10 30 35 15 75 10 40/140
La 15 20 40 40 10 40 10 35/140
Cr 10 15 25 30 45 50 45 44/140
As 15 15 25 25 50 30 65 45/140
Mn 15 20 20 25 15 50 20 33/140
Co 15 15 20 20 80 60 20 46/140
Al 15 15 25 20 25 60 10 34/140
Li 5 15 15 10 20 45 40 30/140
Sc 15 15 0 20 15 15 70 30/140
Ni 10 5 15 40 85 15 45 43/140
In 10 5 15 40 25 25 25 29/140
PAHs and halogentated organic compounds
Benzo[a]pyrene 85 75 70 85 30 40 55 88/140
Anthracene 85 40 60 65 40 45 45 76/140
1,2,5,6,9,10-
Hexabromocyclododecane
(HBCD)
70 20 70 40 25 45/100
Aroclor 1248 15 35 25 25 20 100 40 52/140
Trichloroethylene 55 10 65 50 20 40/100
Fluoranthene 15 10 30 45 25 75 20 44/140
Phenanthrene 25 20 20 25 20 85 25 44/140
Aroclor 1254 15 50 30 15 15 55 30 42/140
Aroclor 1260 5 20 25 20 10 75 45 40/140
Aroclor 1232 5 30 30 15 20 65 50 43/140
Di-n-butyl phthalate solution 30 60 40 25 25 36/100
Aroclor 1016 0 25 30 15 25 65 45 41/140
3,30,5,50-Tetrabromobisphenol A
(TBBPA)
25 20 50 30 25 30/100
Tris(2-chloroethyl)phosphate
(TCEP)
20 25 45 10 20 24/100
Tris(1-chloro-2-propyl) phosphate
(TCPP)
15 15 30 25 45 26/100
Tris(1,3-dichloro-2-propyl)
phosphate (TDCPP)
20 15 30 15 10 18/100
Tricresyl phosphate (TCrP) 15 15 20 10 35 19/100
Dibromochloromethane solution 15 25 5 25 40 22/100
Bis(2-ethylhexyl) phthalate
solution
20 5 5 20 40 18/100
Bromoform solution 10 25 5 15 35 18/100
Tris(2-butoxyethyl)phosphate
(TBEP)
15 20 10 5 40 18/100
Fluoride 15 5 5 10 15 10/100
Pesticides
Prochloraz 50 80 80 80 75 70 70 101/140
Vinclozolin 10 80 75 30 65 90 70 84/140
Malathion 65 35 35 45 75 75 70 80/140
Methyl parathion 40 30 35 40 70 70 65 70/140
Parathion 40 20 40 30 70 65 50 63/140
Hexachlorocyclohexane (HCH) 40 35 45 40 25 50 60 59/140
Fenitrothion 40 25 15 30 20 60 65 51/140
Diazinon 30 15 25 0 15 80 65 46/140
1-Naphthyl-N-methylcarbamate 30 30 5 15 15 80 60 47/140
DDT 25 20 25 10 45 80 60 53/140
Dieldrin 20 20 20 20 50 70 45 49/140
DDE 0 20 30 10 75 80 50 53/140
Glyphosate 0 25 20 30 75 40 35 45/140
Fipronil 20 5 5 15 15 85 20 33/140
Lindane 20 25 5 15 25 18/100
Pharmaceuticals and personal care products
Diethylstilbesterol 40 20 95 75 15 85 80 82/140
17a-Ethinylestradiol 30 15 100 95 15 30 75 72/140
(continued)
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The chemical–assay responses were also subjected to
clustering analyses (Figure 4). Eight clusters were identified
and are briefly described. Clusters 1 to 4 consisted of chemical
groupings that potentiated receptor binding or enzyme activity,
while clusters 5 to 8 were chemicals that inhibited the assay
responses. Cluster 1 included pesticides and PAHs (r¼ 0.85;
fenitrothion, malathion, 1-naphthyl-N-methylcarbamate, diazi-
non, phenanthrene, fluoranthene, Aroclor 1254, Aroclor 1248)
that were associated with an increase in D2 receptor binding in
multiple species (pilot whale, mink, common dolphin, bald
eagle, polar bear, mouse, zebra finch, goldfish). Similarly,
cluster 2 also documented an increase in D2 receptor binding for
several chemicals in the same species listed in cluster 1
(r¼ 0.90; DDE, glyphosate, parathion, Aroclor 1260, Aroclor
1016, Aroclor 1232, hexachlorocyclohexane, methyl para-
thion). Cluster 3 consisted of 2 PAHs, anthracene and benzo(a)
pyrene. These 2 chemicals presented high similarities in terms
of increasing D2 binding (r¼ 0.74) in 14 out of 20 species (all
species except for human, rat, rainbow trout, yellow perch,
chicken, mallard) and for increased NMDA binding in 5 species
(rat, mouse, common dolphin, river otter, Japanese quail).
Cluster 4 included the 2 pharmaceuticals and personal care
products ibuprofen and EE2 (r¼ 0.96), which potentiated
NMDA binding in 14 out of 20 species assayed (all species
except for rat, mouse, human, common dolphin, river otter, and
Japanese quail). Cluster 5 consisted of different pesticides
(fenitrothion, malathion, 1-naphthyl-N-methylcarbamate;
r¼ 0.96) which inhibited GS activity in all species tested.
Cluster 6 indicated that 2 pharmaceuticals (fadrazole, trilostane;
r¼ 0.97) inhibited GS activity in all species tested. Cluster 7
grouped chemicals from different categories (BPA, prochloraz,
spironolactone, Sn, Ce, Ta; r¼ 0.88), and in vitro exposure to
those chemicals resulted in an inhibition of mAChR binding in
15 out of 20 species (all species except for rat, yellow perch,
bald eagle, zebra finch, Japanese quail). Cluster 8 included
pesticides and PAHs (DDE, glyphosate, parathion, Aroclor
1260, Aroclor 1016, Aroclor 1232, hexachlorocyclohexane,
methyl parathion; r¼ 0.97) which inhibited AChE activity in 13
species out of 20 (pilot whale, common dolphin, yellow perch,
rainbow trout, king mackerel, yellowfin tuna, bald eagle, zebra
finch, chicken, Japanese quail, mallard, rat, mouse).
The chemical–assay clustering data set (as well as the other
results) presented provides a rich amount of information that can be
used to help better screen environmental chemicals, prioritize and
focus future activities, explore potential differences across a diverse
number of species, read across chemicals or species, and develop
new hypotheses. While the information contained in the previous
paragraph points to similar clusters, it is important to observe the
exceptions, particularly for species from the same taxonomic group
(i.e., are they reallydifferent, or are there technical errorsunderlying
these assays?) and for chemicals with well-established modes of
action. One may reasonably expect that responses elicited by a
given chemical would cut across species (especially within a taxa),
and thiswas seldomobserved (only in clusters 5 and6), thus leading
us to recognize a need to better characterize assay sensitivity and
specificity (true/false and positive/negative findings).
While it is not feasible to explore all the results in detail, 3
examples are highlighted. First, the 4 PAHs included in our
screening activity were associated with increased D2 receptor
binding in most species. These chemicals have traditionally not
been considered as being neuroactive, though more attention is
being paid to their potential neurodevelopmental effects [22].
Given the ubiquity of PAHs in the environment (e.g., air
pollution, coal tar sealants, oil spills), more research on potential
Table 1. (Continued)
% Species with significant hits for each chemical–assay pairing
Chemicals D2
GABA
BZ NMDA mAChR AChE GS MAO
Species–assay pairs affected by the
chemical listed
Bisphenol-A 60 25 80 100 30 80 35 82/140
Ibuprofen 25 20 100 95 25 30 65 72/140
Indomethacin 35 10 100 80 35 65 40 73/140
Rosuvastatin 20 85 15 60 35 25 75 63/140
Dexamethasone 20 10 85 70 20 75 55 67/140
Triclocarban 10 40 95 55 55 30 35 64/140
Ketoconazole 15 10 75 40 50 80 55 65/140
Spironolactone 35 15 45 70 25 55 60 61/140
Gemfibrozil 30 25 75 55 5 70 45 61/140
17b-Trenbolone 20 15 55 30 60 65 50 59/140
Fadrozole 20 0 45 35 30 65 55 50/140
Trilostane 10 15 20 35 15 45 90 46/140
Cyproterone acetate 25 15 20 50 10 75 35 46/140
Celecoxib 30 15 20 5 20 90 45 45/140
Haloperidol 20 5 20 15 75 95 35 53/140
Acetaminophen 10 20 15 5 45 19/100
Cimetidine 10 5 0 20 50 17/100
Naphthenic acid 15 15 15 5 50 20/100
Caffeine 10 5 0 10 25 10/100
Triclosan 5 5 5 0 50 13/100
Cholesterol 15 5 0 5 35 12/100
Chemical–species pairs affected for
the assay listed
386/1600 369/1600 533/1600 574/1600 554/1600 730/1200 614/1200
aThe main data in the table represent a percentage of the 20 species studied that was affected in a particular chemical–assay pairing, with the final column being a
tally of the number of species–assay pairs significantly affected by the listed chemical and the final row being a tally of the number of chemical–species pairs
significantly affected in the listed assay (within a chemical category, the chemicals are listed in rank order in terms of the number of “hits” found).
AChE¼ acetylcholine esterase; D2¼ dopamine-2; DDE¼ dichlorodiphenyldichloroethylene; DDT¼ dichlorodiphenyltrichloroethane; GABA BZ¼ gamma-
aminobutyric acid receptor benzodiazepine site; GS¼ glutamine synthetase; mAChR¼muscarinic acetylcholine receptor; MAO¼monoamine oxidase;
NMDA¼N-methyl-d-aspartate; PAH¼ polycyclic aromatic hydrocarbon.
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neurodevelopmental effects toward a range of ecological species
may be fruitful. Second, there is growing interest in using read-
across methods particularly for chemicals with limited data. In
the present study we included 5 organophosphate flame
retardants (TCPP, TCEP, TCrP, TBEP, TDCPP) which have
been promoted as replacements for brominated flame retardants
yet for which there exists limited toxicological information. Our
in vitro screen shows that these chemicals acted quite similarly,
thus supporting the potential use of read-across for chemicals
with similarities in structure. Third, we point to a situation in
which we expected an inhibitory response to cut across all
species. We indicated that cluster 8 chemicals inhibited AChE
activity in13out of 20 species and that one of the chemicals in this
cluster was parathion, which is a potent AChE inhibitor. The
present study did not show in vitro effects of parathion toward
AChE in the brain extracts from human, river otter, mink,
goldfish, polar bear, narwhal, or ringed seals, even thoughwhole-
animal studies have shown parathion-related inhibitions in
humans [23] and goldfish [24]. This particular case raises
concerns about assay validity and a particular need to include
positive chemicals, link in vitro and in vivo data sets, and
ultimately strive toward continuing to improve the method.
Limitations and future directions
The cost/performance ratio of these cell-free assays makes
them attractive as tools to screen, prioritize, and evaluate a large
number of chemicals and environmental mixtures and thus help
potentially meet regulatory obligations as well as help satisfy
societal concerns. Despite this promise, there are challenges
with cell-free assays that warrant mention. Foremost is that the
assays represent a simple biological system. They lack the basic
cellular machinery found in traditional in vitro models such as
cell lines and cell cultures, yet one may argue that they may be
more relevant models than can be achieved in silico. They lack
the metabolic capacity of cells, though future endeavors could
aim to increase their realism via coincubations with biological
Figure 2. Clustering of neurochemical cell-free assay results across 20 species against 80 chemicals based on chemical–chemical similarity matrix (Euclidean
distance, complete linkage). The strength of associations is visualized in the heat map from red (negative associations) to blue (positive associations). Chemicals
clustered along the diagonal have the highest associations. Four key clusters were identified.
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cofactors (e.g., S9 fractions). Moving forward, validation
studies that enable comparisons between in vitro data from
cell-free assays and physiological responses from the whole
organism are required to establish these in vitro testing tools as
being reliable and predictive. However, there are challenges
with such a notion given that most of the species in the present
study are not conducive to being tested in an experimental
setting in which neurotoxicity (and other apical measures) can
be taken.
The present study serves as a proof of concept that can be
improved on in many regards. For example, some technical
challenges were outlined previously, and these can be
carefully monitored and potentially remedied by the use of
several quality control mechanisms. As part of a screening
effort that mirrors an approach taken by the USEPA’s ToxCast
program, we only tested a single concentration (i.e., 50mM) of
each chemical. While this is a reasonable start, testing a single
value at a relatively high concentration represents at best a
first-tier screening approach. Positive hits need to be retested
at a range of concentrations to help understand response
potency and efficacy as well as points of departure and to
buffer against potential false-positive results. Conversely, test
chemicals that do not elicit a response at 50mM need to be
tested at different concentrations, especially lower ones, given
the possibility of nonmonotonic concentration–response
profiles. Because the assay is being hailed as one that has
high-throughput potential, scaling up the number of concen-
trations tested should not be difficult but nonetheless requires
added resources and careful consideration. Beyond testing
multiple concentrations of a given chemical, future efforts
could address the possibility of studying complex mixtures as
done in previous efforts [10,11].
The present study was narrowly focused on select
neurochemicals; moving ahead, the number of cell-free assays
can be expanded to increase the size of the biological space
that can be interrogated. The neurochemical systems
investigated are conducive to being modeled into an adverse
outcome pathway framework, and future efforts could strive
toward developing predictive models whereby cell-free results
serve as molecular initiating events and are linked quantita-
tively to apical outcomes of regulatory interest [25]. Such
modeling activities hold great promise though will also
require careful validation studies, particularly through whole-
animal studies on select cases to show a linkage between the
in vitro and in vivo results. We focused on a relatively small
number of well-studied chemicals, and future work can
embark on screening a larger library of chemicals as well as
complex environmental mixtures. Tools that can screen and
prioritize a large number of samples are sorely needed in the
field of environmental toxicology.
Table 2. For each of the 20 species studied, the number of significantly active chemical–assay pairs is summarized as well as the number of active chemicals and
assaysa
Species Active chemical–assay pairs Active chemicals Active assays
Yellow perch 237/540 79/80 7/7
Pilot whale 236/540 78/80 7/7
Human 233/540 80/80 7/7
Rainbow trout 229/540 74/80 7/7
River otter 221/540 79/80 7/7
Yellowfin tuna 213/540 76/80 7/7
Chicken 212/540 77/80 7/7
Mallard 207/540 76/80 7/7
Mink 206/540 78/80 7/7
King mackerel 199/540 78/80 7/7
Japanese quail 197/540 77/80 7/7
Goldfish 197/540 76/80 7/7
Common dolphin 191/540 76/80 7/7
Rat 190/540 71/80 7/7
Polar bear 188/540 77/80 7/7
Bald eagle 186/540 73/80 7/7
Mouse 185/540 72/80 7/7
Narwhal 182/540 76/80 7/7
Ringed seal 166/540 76/80 7/7
Zebra finch 166/540 74/80 7/7
aThe species are listed in decreasing rank order in terms of active “hits”.
Figure 3. Clustering of neurochemical cell-free assay results across 20
species against 80 chemicals based species–species similarity matrix
(Euclidean distance, complete linkage). The strength of associations is
visualized in the heat map from light blue (strongest positive associations) to
dark blue (weakest positive associations). Species clustered along the
diagonal have datasets with the highest associations.
3088 Environ Toxicol Chem 36, 2017 A. Arini et al.
CONCLUDING REMARKS
There is a great need worldwide (by regulatory agencies and
industries alike) to accelerate the development and application
of new approach methodologies, including in vitro toxicity
testing tools for the purposes of ecological risk assessment [5].
We have previously developed and applied neurochemical-
based, cell-free assays to screen environmental mixtures [10,11]
and chemicals [12,13] against a range of ecological species
including some that are very difficult to study such as ringed
seals [13].We scaled up our activities to apply a set of 7 cell-free
neurochemical screening assays to serve as a screening platform
Figure 4. Hierarchical clustering of 80 chemicals by 8 assays and 20 species (Euclidean distance, complete linkage). The cluster is based on chemical–assay
potency as measured by the relative percentage of binding/activity compared to nonexposed controls. The strength of associations is visualized in the heat map
with gray cells indicating no change, red cells indicating inhibition, and blue cells indicating activation. Eight key clusters were identified.
A species agnostic cell-free neurochemical screening assay Environ Toxicol Chem 36, 2017 3089
to evaluate 80 chemicals across 20 species. In general, the
results show that cell-free tests may be an attractive tool to
predictive ecotoxicology, especially given the limited avail-
ability of test organisms (particularly species that are at risk,
difficult to maintain in captivity, etc.), lack of proven cell-based
tools (e.g., primary and cell-line based cultures), societal
concerns over animal testing, and the sheer number of
ecological species to study as well as vast interspecies
differences that pose barriers. Performing comparable research
in whole animals would have taken many years and millions of
dollars. Despite potential benefits, there are key limitations that
must be recognized, and future work is needed to demonstrate
that these assays are indeed useful to end-user groups.
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Online Library at DOI: 10.1002/etc.3880.
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